Publicação

Insights into therapeutic liquid mixtures and formulations towards tuberculosis therapy

Ver documento

Detalhes bibliográficos
Resumo:Therapeutic liquid mixtures, as deep eutectic systems, are considered a sustainable strategy that can be useful for the modification and enhancement of the pharmacokinetics and pharmacodynamics of different active ingredients. In this study, we assessed the stability and antibacterial activity of therapeutic liquid formulations prepared with anti-tuberculosis drugs. Tuberculosis therapy presents various pitfalls related, for example, to the administration of prolonged regimens of multiple drugs, different severe adverse effects, low compliance of the patient to treatment and the development of drug resistance. During this study, it was possible to assess the physicochemical stability of the formulations for 6 months, by polarized optical microscopy, 1H NMR and FTIR-ATR. Furthermore, the mixtures present an antibacterial effect against a drug-susceptible Mycobacterium tuberculosis strain (H37Rv). This was particularly evident for the mixtures with ethambutol incorporated, making them interesting to pursue with further studies and evaluation of clinical applicability. Upon infection, it was also observed that a single and higher dose appears to be more effective than lower separate doses, which could allow the production of patient-friendly formulations.
Autores principais:Santos, Filipa
Outros Autores:Pires, David; Anes, Elsa; Duarte, Ana Rita C.
Assunto:Anti-tuberculosis drugs Eutectic mixtures Therapeutic liquid mixtures Tuberculosis
Ano:2023
País:Portugal
Tipo de documento:artigo
Tipo de acesso:acesso aberto
Instituição associada:Universidade de Lisboa
Idioma:inglês
Origem:Repositório da Universidade de Lisboa
_version_ 1866811095463755776
author Santos, Filipa
author2 Pires, David
Anes, Elsa
Duarte, Ana Rita C.
author2_role author
author
author
author_facet Santos, Filipa
Pires, David
Anes, Elsa
Duarte, Ana Rita C.
author_role author
contributor_name_str_mv Repositório Científico de Acesso Aberto da ULisboa
country_str PT
creators_json_txt [{\"Person.name\":\"Santos, Filipa\"},{\"Person.name\":\"Pires, David\",\"Person.identifier.orcid\":\"0000-0001-9602-1516\"},{\"Person.name\":\"Anes, Elsa\",\"Person.identifier.orcid\":\"0000-0001-5934-0198\"},{\"Person.name\":\"Duarte, Ana Rita C.\",\"Person.identifier.orcid\":\"0000-0003-0800-0112\"}]
datacite.contributors.contributor.contributorName.fl_str_mv Repositório Científico de Acesso Aberto da ULisboa
datacite.creators.creator.creatorName.fl_str_mv Santos, Filipa
Pires, David
Anes, Elsa
Duarte, Ana Rita C.
datacite.date.Accepted.fl_str_mv 2023-03-01T00:00:00Z
datacite.date.available.fl_str_mv 2023-08-24T16:23:04Z
datacite.date.embargoed.fl_str_mv 2023-08-24T16:23:04Z
datacite.rights.fl_str_mv http://purl.org/coar/access_right/c_abf2
datacite.subjects.subject.fl_str_mv Anti-tuberculosis drugs
Eutectic mixtures
Therapeutic liquid mixtures
Tuberculosis
datacite.titles.title.fl_str_mv Insights into therapeutic liquid mixtures and formulations towards tuberculosis therapy
dc.contributor.none.fl_str_mv Repositório Científico de Acesso Aberto da ULisboa
dc.creator.none.fl_str_mv Santos, Filipa
Pires, David
Anes, Elsa
Duarte, Ana Rita C.
dc.date.Accepted.fl_str_mv 2023-03-01T00:00:00Z
dc.date.available.fl_str_mv 2023-08-24T16:23:04Z
dc.date.embargoed.fl_str_mv 2023-08-24T16:23:04Z
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv http://hdl.handle.net/10451/59009
dc.language.none.fl_str_mv eng
dc.publisher.none.fl_str_mv Elsevier
dc.rights.cclincense.fl_str_mv http://creativecommons.org/licenses/by/4.0/
dc.rights.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.subject.none.fl_str_mv Anti-tuberculosis drugs
Eutectic mixtures
Therapeutic liquid mixtures
Tuberculosis
dc.title.fl_str_mv Insights into therapeutic liquid mixtures and formulations towards tuberculosis therapy
dc.type.none.fl_str_mv http://purl.org/coar/resource_type/c_6501
description Therapeutic liquid mixtures, as deep eutectic systems, are considered a sustainable strategy that can be useful for the modification and enhancement of the pharmacokinetics and pharmacodynamics of different active ingredients. In this study, we assessed the stability and antibacterial activity of therapeutic liquid formulations prepared with anti-tuberculosis drugs. Tuberculosis therapy presents various pitfalls related, for example, to the administration of prolonged regimens of multiple drugs, different severe adverse effects, low compliance of the patient to treatment and the development of drug resistance. During this study, it was possible to assess the physicochemical stability of the formulations for 6 months, by polarized optical microscopy, 1H NMR and FTIR-ATR. Furthermore, the mixtures present an antibacterial effect against a drug-susceptible Mycobacterium tuberculosis strain (H37Rv). This was particularly evident for the mixtures with ethambutol incorporated, making them interesting to pursue with further studies and evaluation of clinical applicability. Upon infection, it was also observed that a single and higher dose appears to be more effective than lower separate doses, which could allow the production of patient-friendly formulations.
dirty 0
eu_rights_str_mv openAccess
format article
fulltext.url.fl_str_mv https://repositorio.ulisboa.pt/bitstreams/e65e7a3d-0d62-4515-8036-20622bf10ef4/download
funding.funder.alternateName_str_mv FCT
FCT
funding.funder.identifier_str_mv http://doi.org/10.13039/501100001871
http://doi.org/10.13039/501100001871
funding.funder.name_str_mv Fundação para a Ciência e a Tecnologia
Fundação para a Ciência e a Tecnologia
funding.name_str_mv 6817 - DCRRNI ID
6817 - DCRRNI ID
id ul_47f09f074e2ebc0300d111b9fceb897a
identifier.url.fl_str_mv http://hdl.handle.net/10451/59009
instacron_str ul
institution Universidade de Lisboa
instname_str Universidade de Lisboa
language eng
network_acronym_str ul
network_name_str Repositório da Universidade de Lisboa
oai_identifier_str oai:repositorio.ulisboa.pt:10451/59009
organization_str_mv urn:organizationAcronym:ul
person_str_mv Santos, Filipa
Pires, David
Pires, David
https://www.ciencia-id.pt/5816-D53E-F354
5816-D53E-F354
http://orcid.org/0000-0001-9602-1516
0000-0001-9602-1516
Anes, Elsa
Anes, Elsa
https://www.ciencia-id.pt/1A10-7DAD-D860
1A10-7DAD-D860
http://orcid.org/0000-0001-5934-0198
0000-0001-5934-0198
Duarte, Ana Rita C.
Duarte, Ana Rita C.
https://www.ciencia-id.pt/EC16-491B-8A13
EC16-491B-8A13
http://orcid.org/0000-0003-0800-0112
0000-0003-0800-0112
publishDate 2023
publisher.none.fl_str_mv Elsevier
reponame_str Repositório da Universidade de Lisboa
repository_id_str urn:repositoryAcronym:ul
service_str_mv urn:repositoryAcronym:ul
spelling engElsevierpt_PTTherapeutic liquid mixtures, as deep eutectic systems, are considered a sustainable strategy that can be useful for the modification and enhancement of the pharmacokinetics and pharmacodynamics of different active ingredients. In this study, we assessed the stability and antibacterial activity of therapeutic liquid formulations prepared with anti-tuberculosis drugs. Tuberculosis therapy presents various pitfalls related, for example, to the administration of prolonged regimens of multiple drugs, different severe adverse effects, low compliance of the patient to treatment and the development of drug resistance. During this study, it was possible to assess the physicochemical stability of the formulations for 6 months, by polarized optical microscopy, 1H NMR and FTIR-ATR. Furthermore, the mixtures present an antibacterial effect against a drug-susceptible Mycobacterium tuberculosis strain (H37Rv). This was particularly evident for the mixtures with ethambutol incorporated, making them interesting to pursue with further studies and evaluation of clinical applicability. Upon infection, it was also observed that a single and higher dose appears to be more effective than lower separate doses, which could allow the production of patient-friendly formulations.application/pdfpt_PTInsights into therapeutic liquid mixtures and formulations towards tuberculosis therapySantos, FilipaPersonalPires, DavidDSpacehttp://dspace.org/items/33f8bd0a-4d69-4202-a087-a8de16eb2168DSpacehttp://dspace.org/items/33f8bd0a-4d69-4202-a087-a8de16eb2168RODRIGUES PIRESDAVID ALEXANDRECiência IDhttps://www.ciencia-id.pt5816-D53E-F354ORCIDhttp://orcid.org0000-0001-9602-1516Scopus Author IDhttps://www.scopus.com50162243000PersonalAnes, ElsaDSpacehttp://dspace.org/items/8a820e65-a46a-4617-99a6-c2f0a88e1103DSpacehttp://dspace.org/items/8a820e65-a46a-4617-99a6-c2f0a88e1103RIBEIRO DOS SANTOS ANESELSA MARIACiência IDhttps://www.ciencia-id.pt1A10-7DAD-D860ORCIDhttp://orcid.org0000-0001-5934-0198Scopus Author IDhttps://www.scopus.com6507064447PersonalDuarte, Ana Rita C.DSpacehttp://dspace.org/items/1284713d-8806-4798-9837-714d3d853685DSpacehttp://dspace.org/items/1284713d-8806-4798-9837-714d3d853685DuarteAnaCiência IDhttps://www.ciencia-id.ptEC16-491B-8A13ORCIDhttp://orcid.org0000-0003-0800-0112Scopus Author IDhttps://www.scopus.com7102601957Scopus Author IDhttps://www.scopus.com7102601957HostingInstitutionOrganizationalRepositório Científico de Acesso Aberto da ULisboae-mailmailto:repositorio@reitoria.ulisboa.ptrepositorio@reitoria.ulisboa.ptISSNIsPartOf0378-5173DOIIsPartOf10.1016/j.ijpharm.2023.1228622023-08-24T16:23:04Z2023-032023-06-02T16:31:52Z2023-03-01T00:00:00ZHandlehttp://hdl.handle.net/10451/59009http://purl.org/coar/access_right/c_abf2open accessAnti-tuberculosis drugsEutectic mixturesTherapeutic liquid mixturesTuberculosis2126029 bytesFundação para a Ciência e a TecnologiaAssociated Laboratory for Green Chemistry - Clean Technologies and Processes6817 - DCRRNI IDCrossref Funder IDhttp://doi.org/10.13039/501100001871Fundação para a Ciência e a TecnologiaResearch Institute for Medicines6817 - DCRRNI IDCrossref Funder IDhttp://doi.org/10.13039/501100001871literaturehttp://purl.org/coar/resource_type/c_6501journal article2023-03http://creativecommons.org/licenses/by/4.0/http://purl.org/coar/access_right/c_abf2application/pdffulltexthttps://repositorio.ulisboa.pt/bitstreams/e65e7a3d-0d62-4515-8036-20622bf10ef4/downloadInternational Journal of Pharmaceutics637122862
spellingShingle Insights into therapeutic liquid mixtures and formulations towards tuberculosis therapy
Santos, Filipa
Anti-tuberculosis drugs
Eutectic mixtures
Therapeutic liquid mixtures
Tuberculosis
status SINGLETON
subject.fl_str_mv Anti-tuberculosis drugs
Eutectic mixtures
Therapeutic liquid mixtures
Tuberculosis
title Insights into therapeutic liquid mixtures and formulations towards tuberculosis therapy
title_full Insights into therapeutic liquid mixtures and formulations towards tuberculosis therapy
title_fullStr Insights into therapeutic liquid mixtures and formulations towards tuberculosis therapy
title_full_unstemmed Insights into therapeutic liquid mixtures and formulations towards tuberculosis therapy
title_short Insights into therapeutic liquid mixtures and formulations towards tuberculosis therapy
title_sort Insights into therapeutic liquid mixtures and formulations towards tuberculosis therapy
topic Anti-tuberculosis drugs
Eutectic mixtures
Therapeutic liquid mixtures
Tuberculosis
topic_facet Anti-tuberculosis drugs
Eutectic mixtures
Therapeutic liquid mixtures
Tuberculosis
url http://hdl.handle.net/10451/59009
visible 1